These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9413826)

  • 21. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
    Johnson BD; Hanke CA; Becker EE; Truitt RL
    Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunopotentiation of novel adjuvant SWZY on the poorly immunogenic murine melanoma vaccine].
    Zhou Y; Qi X; Xiao JX; Lai BC; Si LS; Wang YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):526-9. PubMed ID: 16806024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroid cells in immunoregulation: characterization of a novel suppressor factor.
    Seledtsova GV; Seledtsov VI; Samarin DM; Senyukov VV; Ivanova IP; Akimenko ZA; Tsyrlova IG; Wolpe SS; Kozlov VA
    Immunol Lett; 2004 May; 93(2-3):171-8. PubMed ID: 15158614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200.
    Boudakov I; Liu J; Fan N; Gulay P; Wong K; Gorczynski RM
    Transplantation; 2007 Jul; 84(2):251-7. PubMed ID: 17667818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antitumor effect of the extract of birch bark and its influence to the immune function].
    Han S; Li Z; Li Y; Zhong R
    Zhong Yao Cai; 2000 Jun; 23(6):343-5. PubMed ID: 12575089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on effects of anticancer and immunoregulation of Fuganchun 6 on hepatoma of mouse].
    Li XJ; Mao YX; Zhang HL; Wang JX; Liu FY
    Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(19):1622-5. PubMed ID: 17165590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
    Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory activity of a potent thymopentin analog: disulphide bridged beta-mercaptopropionyl-arginyl-lysyl-aspartyl-valyl-tyrosyl-cysteine amide.
    Wieczorek Z; Zimecki M; Trojnar J; Siemion IZ
    Pol J Pharmacol; 1996; 48(1):31-8. PubMed ID: 9112625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro].
    Liu CL; Dou KF; Zang XX; Zhu BF; Chen SM
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):554-8. PubMed ID: 15196371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostimulatory activity of the bacterial extract OM-8.
    Huber M; Ayoub M; Pfannes SD; Mittenbühler K; Weis K; Bessler WG; Baier W
    Eur J Med Res; 2000 Mar; 5(3):101-9. PubMed ID: 10756163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental research on immunological activity of Polyactin A.
    Zeng XY
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():204-5. PubMed ID: 7886574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The study on the expression of membrane HSP70 protein in H22 cell and its immunoprotective mechanism against carcinoma.
    Wu WZ; Liu KD; Xie Q; Wu HS
    J Exp Clin Cancer Res; 1999 Dec; 18(4):543-8. PubMed ID: 10746982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice.
    Chew BP; Wong MW; Park JS; Wong TS
    Anticancer Res; 1999; 19(6B):5223-7. PubMed ID: 10697539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor cytotoxins in the early stages of liver carcinogenesis].
    Korosteleva TA; Potapenkova LS
    Vopr Onkol; 1981; 27(1):68-72. PubMed ID: 7456444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunopotentiating effects of oxalysine].
    Li XY; Tong LM; Jin YF; Cao CY; Liang HZ; Wang JF; Zhu PP; Wang JY
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):173-7. PubMed ID: 2959008
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antitumor activity of the lymphoid spleen cells of hepatectomized C3HA strain mice].
    Malygin AM; Fel' VIa
    Tsitologiia; 1982 Dec; 24(12):1460-2. PubMed ID: 7157475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of oxalysine on plasma fibrinogen content in tumor-bearing mice (author's transl)].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):124-8. PubMed ID: 6214145
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of alpha fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4 oxalysine on the expression.
    Wang XW; Xu B
    World J Gastroenterol; 1998 Aug; 4(4):294-297. PubMed ID: 11819302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The anticancer and pharmacologic study of oxalysine (author's transl)].
    Yue XF; Wu FG; Xu B
    Yao Xue Xue Bao; 1980 Jul; 15(7):391-5. PubMed ID: 6775491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.